Durvalumab (active substance) - analogs
Pharmgroups: Antitumor agents - monoclonal antibodies |
|||||||||
| Prices in pharmacies: Instructions Durvalumab | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Durvalumab included in the composition |
Prices in pharmacies |
| Imfinzi | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 30% Crizotinib
- 25% Pembrolizumab
- 24% Osimertinib
- 24% Gefitinib
- 24% Ceritinib
- 24% Afatinib
- 20% Nivolumab
- 20% Ipilimumab
- 20% Avelumab
- 20% Pentetreotide
- 20% Isatuximab
- 20% Trastuzumab emtansine
- 18% Obinutuzumab
- 18% Elotuzumab
- 18% Blinatumomab
- 18% Inotuzumab ozogamicin
- 18% Ofatumumab
- 18% Catumaxomab
- 17% Prolgolimab
- 16% Pertuzumab
- 16% Lorlatinib
- 16% Daratumumab
- 15% Vinorelbine
- 15% Pemetrexed
- 15% Ramucirumab
- 14% Atezolizumab
- 14% Trastuzumab
- 13% Cetuximab
- 13% Bevacizumab
- 13% Vinflunine
- 12% Trametinib
- 11% Altretamine
- 11% Demecolcine
- 10% Remifentanil
- 10% Enzalutamide
- 10% Lenalidomide
- 10% Molgramostim
- 10% Piritramide
- 10% Viomycin
- 10% Streptozocin
Learn more about the selection of analogues
- The drug has «Durvalumab» 41 analog by action, the most similar - Crizotinib .
- Medical online service has selected the best substitutes for Durvalumab based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Durvalumab analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.